| (210) | Number of the EPO application | 17740237 |
| (220) | Filing date of the EPO application | 2017.07.06 |
| (80) | EPO patent specification publication (B) | EPB nr. 49/2023, 2023.12.06 |
| (110) | EPO patent number | 3481837 |
| (21) | Number of the application | e 2019 0577 |
| (71) | Name(s) of applicant(s), code of the country | Cyclerion Therapeutics, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | SHEPPECK James Edward, US;
RENHOWE Paul Allan, US;
MERMERIAN Ara, US;
BARDEN Timothy Claude, US;
RENNIE Glen Robert, US;
IYENGAR Rajesh R., US;
NAKAI Takashi, US; |
| (73) | Name(s) of owner(s), code of the country | Cyclerion Therapeutics, Inc., US; |
| (54) | Title of the invention | PHOSPHORUS PRODRUGS OF SGC STIMULATORS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07F 9/09 (2006.01.01); A61K 31/506 (2006.01.01); A61K 31/422 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.06.30 |
| (30) | Priority | 201662359419 P, 2016.07.07, US |
| (86) | International application | PCT/US2017/040809, 2017.07.06 |
| (87) | International publication | WO 2018/009596, 2018.01.11 |